Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H33NO3.ClH |
| Molecular Weight | 395.963 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 11 / 11 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@@]12[C@@H]3C[C@H]4[C@@]1([C@@H](O)CC[C@@]4(C)CN2CC)[C@]5([H])C[C@H](O)[C@@H]6C[C@]35[C@H](O)C6=C
InChI
InChIKey=PZXQMICJIDMSSE-LYWLWKIFSA-N
InChI=1S/C22H33NO3.ClH/c1-4-23-10-20(3)6-5-17(25)22-15(20)7-13(18(22)23)21-9-12(11(2)19(21)26)14(24)8-16(21)22;/h12-19,24-26H,2,4-10H2,1,3H3;1H/t12-,13+,14+,15-,16-,17+,18-,19-,20+,21+,22+;/m1./s1
Napelline is a diterpenoid alkaloid, from plants of the Aconitum genus, Ranunculaceae. It is a potent antiarrhythmic of class I with weak hypotensive and N-cholinoblocking effects. Napelline has analgesic and anti-inflammatory activity. Napelline has a stronger antiarrhythmic activity than Quinidine or Procaïnamide.
10(-4) - 10(-5) M block inward Na+ currents
CNS Activity
Approval Year
Sample Use Guides
Mice: Napelline (0.025 mg/kg) exhibited an analgesic effect in the acetylcholine cramps model by prolonging the time before manifestation of the nociceptive
reaction and reducing the number of cramps.
Route of Administration:
Intravenous
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
V698CDU146
Created by
admin on Sat Dec 16 10:03:16 GMT 2023 , Edited by admin on Sat Dec 16 10:03:16 GMT 2023
|
PRIMARY | |||
|
6197-47-3
Created by
admin on Sat Dec 16 10:03:16 GMT 2023 , Edited by admin on Sat Dec 16 10:03:16 GMT 2023
|
PRIMARY | |||
|
86278129
Created by
admin on Sat Dec 16 10:03:16 GMT 2023 , Edited by admin on Sat Dec 16 10:03:16 GMT 2023
|
PRIMARY | |||
|
m7722
Created by
admin on Sat Dec 16 10:03:16 GMT 2023 , Edited by admin on Sat Dec 16 10:03:16 GMT 2023
|
PRIMARY | Merck Index |
SUBSTANCE RECORD
